This text of Illinois § 1.11 (Meningococcal disease brochure) is published on Counsel Stack Legal Research, covering Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
The Department of Public Health shall develop an informational brochure relating to meningococcal disease that states that immunizations against meningococcal disease are available. The Department of Public Health shall make the brochure available on its website and shall notify every public institution of higher education in the State of the availability of the brochure. Each public institution of higher education shall provide a copy of the brochure to all students and if the student is under 18 years of age, to the student's parent or guardian. Such information in the brochure shall include:
(1)the risk factors for and symptoms of meningococcal disease, how it may be diagnosed, and its possible consequences if untreated;
(2)how meningococcal disease is transmitted;
Free access — add to your briefcase to read the full text and ask questions with AI
The Department of Public Health shall develop an informational brochure relating to meningococcal disease that states that immunizations against meningococcal disease are available. The Department of Public Health shall make the brochure available on its website and shall notify every public institution of higher education in the State of the availability of the brochure. Each public institution of higher education shall provide a copy of the brochure to all students and if the student is under 18 years of age, to the student's parent or guardian. Such information in the brochure shall include: (1) the risk factors for and symptoms of meningococcal disease, how it may be diagnosed, and its possible consequences if untreated; (2) how meningococcal disease is transmitted; (3) the latest scientific information on meningococcal disease immunization and its effectiveness, including information on all meningococcal vaccines receiving a Category A or B recommendation from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices; (4) a statement that any questions or concerns regarding immunization against meningococcal disease may be answered by contacting the individual's health care provider; and (5) a recommendation that the current student or entering student receive meningococcal vaccines in accordance with current guideline from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.